The Flushing Patient

  • Uploaded by: liu_owen17
  • 0
  • 0
  • May 2020
  • PDF

This document was uploaded by user and they confirmed that they have the permission to share it. If you are author or own the copyright of this book, please report to us by using this DMCA report form. Report DMCA


Overview

Download & View The Flushing Patient as PDF for free.

More details

  • Words: 1,077
  • Pages: 35
The flushing patient: Differential diagnosis, workup, and treatment J Am Acad Dermatol 2006;55:193-208

Introduction • Cutaneous flushing – Resulting from changes in cutaneous blood flow triggered by multiple conditions – Common, benign diseases, such as rosacea or climacterum – Other serious diagnoses; carcinoid syndrome, pheochromocytoma, mastocytosis, and anaphylaxis

Definition • Defined as a sensation of warmth accompanied by visible reddening of the skin. • Usu. Most prominent in the classis “bluish area,” including the face, neck and upper portion of the chest, and upper limbs

Definition II • Flushing – episodic or constant • Episodic attacks are generally mediated by release of endogenous vasoactive mediators or by drugs • Repetitive episodes over long periods (persistent flushing) • May produce fixed facial erythema with telangiectases and a cyanotic tinge

Differential Diagnosis

Fever • Most common cause of “hot flushes”, associated with night sweats • Prompt a fever workup, which may reveal an infectious or noninfectious cause

Benign Cutaneous Flushing • Triggered by emotion, exercise, temperature changes, and foods or beverages, esp. spicy foods • Associated findings – a feeling of warmth and cognitive dysfunction • Hyperthermia, Emotional flushing, Foods, beverages, and alcohol

Rosacea • Acne rosacea- another common cause • May present with transient or persistent central facial flushing, erythmea, visible blood vessels, and often papules and pustules • 4 broad subtypes: erythematotelangiectatic, papulopustular, phymatous, and ocular

Rosacea

Rosacea II • Primary manifestation – Persistent erythema, usu. Longer than 3 months – Flushing episodes, lasting longer than 10 mins

• Important to exclude polycythemia vera, connective tissue disease, carcinoid syndrome, systemic mastocytosis

Climacteric Flushing • Common cause of flushing, affecting 50%~85% of women who undergo natural menopause • Perimenopausal flushing presents as transient episodes of intense heat sensation, flushing of the chest, head, and neck, and profuse drenching sweats • Frequently followed by chills, palpitations and a sense of anxiety • Episodes last 3-5 mins and may occur as many as 20 times a day

Carcinoid Syndrome • Classical triad: flushing, GI hypermotility and Rt sided cardiac failure. Lesser incidence of bronchoconstriction • 95% of p’ts have flushing at some point during disease; the most frequent sign • CS occurs in 10% of p’ts with carcinoid tumors; malignant enterochromaffin or Kulchitsky cells derived from neuroendocrine lineage • 13% had metastasis at time of diagnosis and 24% carcinoid p’ts had more than 1 tumor

Carcinoid Syndrome II • Flushes ossicated with gastric tumors are reddish-brown with variegated margination and occurs as wheals over the entire body, including palms and soles and intensely pruritic • Flushes assoicated with bronchoconstriction are bright red and confluent, cover most of the body, last hours to days, and usu. Associated with chemosis, facial edema, severe hypotension, and oliguria • P’ts with CS flushing may develop thick skin changes with venous telangiectasia and bluish coloration of the chin, nose and malar area

Carcinoid Syndrome III • P’ts generally presents with hypotension and tachycardia during flushing • Flushing may be provoked by foods, pharmalocologic triggers and any stimuli that increase adrenergic activity • Likelihood of flushing in CS is dependent on tumor-derived mediators and the extent of liver metastasis

Carcinoid Syndrome IV • Tumor derived vasodilator : 5-HT, substance P, histamine, serotonin, catecholamines, PG, kallikrein, kinins, tachykinins, neuropeptide P, VIP, motilin, and gastric related peptides • CS diagnosed by measuring 24-hr urine 5HIAA, a major urinary metabolite of 5-HT • Flushing in CS can be blocked with somatostatin, analogs also decrease tumor progression

Pheochromocytoma • Also known as chromaffin tumor, present with flushing and hypertension • Chromaffin cells derived most often from the adrenal medulla, produce, store and release catecholamines • HTN most common finding. • Attacks last a few minutes to a few hours • Associated with flushing or pallor, elevated BP and tachycardia • Commonly present with headaches, sweating, palpitations, a sense of apprehension and impending doom, chest or abd pain.

Pheochromocytoma II • Diagnosed by 24hr urine fractionated metanephrines, metabolites of catecholamines • Abdominal CT, abdominal aortography or nuclear scintigraphy with radioactive iodine • Surgical resection by laparoscopic adrenalectomy is the definitive treatment and may be curative

Mastocytosis • A rare disease caused by tissue infiltration with increased numbers of mast cells • More common in childhood than in adulthood • Presents in the children with the characteristic skin eruption of urticaria pigmentosa (>90%)

Urticaria pigmentosa

Darier sign • Darier sign is a change observed after stroking the skin of a person with systemic mastocytosis or urticaria pigmentosa. In general, the skin becomes swollen, itchy and red. • Result of stimulation; mast cells release several potent vasodilators; histamine and PG D2, TNF α

Mastocytosis II • Diagnosis usu. straightforward if characteristic lesions of urticaria pigmentosa present • Elevated plasma concentrations of mast cell mediators, such as histamine and tryptase • Elevated 24hr urine excretion of histamine and PG D2 • Histopathologic analysis of cutaneous mastocytosis lesions revealing multifocal or diffuse mast cell aggregates

Mastocytosis III •

Classified into 4 categories I.

Indolent mastocytosis, cutaneous or systemic II. Mastocytosis associated with hematologic disease III. Lymphadenopathic mastocytosis with eosinophilia IV. Mast cell leukemia

Mastocytosis IV • No cure for mastocytosis • Avoidance of precipitating factors • Flushing and hypotension from mastocytosis can be reversed with IV epinephrine • Combined blockade pf H1 and H2 receptors prevents the vasodilatory effects of histamine

Anaphylaxis • Life threatening condition that may present with flushing • Most often presents with flushing, urticaria and angioedema • Hypotension, upper airway edema, pulmonary symptoms, rhinitis, headaches and substernal chest pain

Medullary Ca. of the thyroid • Malignant tumor of the parafollicular C cells • May present with protracted flushing of the face and upper extremities, discoloration, and telangiectasias • Neoplastic cells are derived from neural crest • Inheritance pattern may be sporadic or AD

Pancreatic cell tumor • Vasoactive intestinal polypeptide (VIP) tumor classically present with VernerMorrison syndrome: watery diarrhea, hypokalemia, and achlorhydria • Also rarely present with flushing during attacks • VIP tumor is diagnosed by a high plasma VIP level in the setting of stool volume greater than 1L per day

Renal cell carcinoma • RCC may cause flushing via secretion of prostaglandin or via pituitary downregulation from release of gonatotropins • Classic triad: gross hematuria, flank pain and abdominal mass • Tx of choice: Nephrectomy

Pharmacologic mediators

Pharmacologic mediators

Differential Diagnosis

Unilateral flushing • May result from contralateral sympathetic nerve lesions that produce Horner syndrome (ptosis, miosis, and anhidrosis) • Leading to contralateral, unaffected facial reddening

Medications

Summary

Summary

Related Documents

The Flushing Patient
May 2020 13
Flushing Out The Aboiteaux
December 2019 11
The Patient
October 2019 37
The Hiv Positive Patient
December 2019 20
Tool - The Patient
October 2019 25